ÂÜÀòÂÒÂ×

With significant experience in both industrial and academic research, Mike has published extensively on genomic analysis and cancer research. Combining his research skills with his significant experience in business development, in 2010 Mike founded and became CEO of Cell Guidance Systems which has developed a plug-and-play protein therapeutic platform that offers potential for many intractable diseases.